ITM and Ariceum Therapeutics Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225
13 janv. 2025 08h00 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich / Berlin, Germany, January 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Ariceum Therapeutics (Ariceum), a private biotech...
Nuclear Medicine Market to hit USD 54.7 billion by 2032, says Global Market Insights Inc.
08 janv. 2025 05h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Nuclear Medicine Market size reached USD 13.6 billion in 2023 and is poised for robust growth, with a projected CAGR of 16.3% from 2024 to...
Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply
03 déc. 2024 07h30 HE
|
Plus Therapeutics Inc.
Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference
25 nov. 2024 07h30 HE
|
Plus Therapeutics Inc.
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases
22 nov. 2024 07h30 HE
|
Plus Therapeutics Inc.
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay
Optical Imaging Agent Market Expected to Expand at 8.1% CAGR, Reaching US$ 3,533.2 Million by 2034 | Fact.MR Report
21 nov. 2024 07h30 HE
|
FACT.MR
Rockville, MD, Nov. 21, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global optical imaging agent market is estimated to reach a...
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
04 nov. 2024 07h30 HE
|
Lantheus Holdings, Inc.
BEDFORD, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight...
ITM and NTP Strengthen Global Radioisotope Production Capacities by Renewing their Technology License Agreement and Signing a Manufacturing and Supply Agreement for n.c.a. Lutetium-177
18 oct. 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Extension of 2012 agreement grants NTP the rights to manufacture and distribute non-carrier-added Lutetium-177 (n.c.a. 177Lu)Companies enter into an additional manufacturing and supply...
Radiopharmaceuticals Market to Expand at a Stellar 9.8% CAGR through 2031 | SkyQuest Technology
16 oct. 2024 09h30 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Oct. 16, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Radiopharmaceuticals Market will attain a value of USD 8 billion by 2031, with a CAGR of 9.8% over the forecast period...
Radiopharmaceuticals Market Size Projected to Soar to USD 16.6 Billion by 2032 with 10.4% CAGR – SNS Insider
04 oct. 2024 09h00 HE
|
SNS Insider pvt ltd
Pune, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Radiopharmaceuticals Market Analysis: According to SNS Insider, the Radiopharmaceuticals Market Size was estimated at USD 5.0 billion in 2023 and is...